ArticleJournal of fluorescence2025
Red Emissive Carbon Dots as Fluorescent Probe for Specific Sensing and Imaging of HCIO.
Article in Journal of fluorescence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Selective detecting and tracking of HClO is crucial for reflecting related oxidative stress process and environmental safety. In this research, we present the red emissive carbon dots (CDs) with advantageous optical performances including high fluorescent stability, strong intensity and advanced quantum yield. The CDs showed excellent selectivity and sensitivity towards HClO with superior anti-interference performance and outstanding detection limit, indicating the CDs based fluorescent nanoprobe is not only highly suitable for detecting HClO in complicated water samples by solution, but also serve as prospective fluorescent filer paper sensor for fast detection. The low cytotoxicity and favorable biocompatibility are extremely demanded for sensing and imaging exogenous and endogenous HClO in living cells, and encourages the CDs as powerful imaging tool to unveil the mystery of HClO participant oxidative stress process, which would be beneficial for early diagnosis and therapeutics of related diseases.Clinical Trial Number Not applicable.
Indexed as
Identifiers
40542983What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.